Streetbeat News

Products Services

SONN

Sonnet BioTherapeutics' shares rise following a licensing agreement with Alkem Laboratories for the development and commercialization of SON-080, targeting diabetic peripheral neuropathy.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:47 pm

SONN

Sonnet BioTherapeutics has entered a licensing agreement with Alkem Laboratories for the development and commercialization of SON-080 in India, targeting diabetic peripheral neuropathy. Sonnet will receive $1M upfront, up to $1M in milestone payments, and low double-digit royalties on net sales. Alkem will fund and commercialize SON-080 for chemotherapy-induced and autonomic neuropathy in India, with the market expected to grow significantly by 2030.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:45 pm

CANF

Can-Fite Biopharma's shares rose following the FDA's orphan drug designation for its drug namodenoson, aimed at treating pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:40 pm

NVTS

Navitas Semiconductor has expanded its GaNSafe portfolio, which could enhance its market position in the semiconductor industry.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:38 pm

SPPL

SIMPPLE Ltd. (NASDAQ:SPPL) has announced new contracts and partnerships in Australia and New Zealand, projected to generate approximately $2.35 million in revenue. These contracts involve providing integrated cleaning services and compliance solutions to various sectors, including aviation, education, manufacturing, and retail.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:38 pm

GILD

Gilead Sciences will present new data on its antiviral portfolio at IDWeek 2024, including findings from HIV, COVID-19, and RSV research. Highlights include Phase 3 trial results for HIV prevention and treatment, and real-world evidence supporting Veklury for COVID-19.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:36 pm

ALMS

MRK

SOUN

TGT

U

Jim Cramer expressed his interest in buying Target Corporation (TGT) and Merck (MRK) stocks, while dismissing SoundHound AI (SOUN) as a 'meme stock'. Target recently appointed Jim Lee from PepsiCo as its CFO. Unity Software (U) received an Underperform rating from Macquarie, and Alumis (ALMS) is considered highly speculative by Cramer.

Portfolio Pulse from Avi Kapoor

October 09, 2024 | 12:36 pm

INBS

Intelligent Bio Solutions has partnered with Spirit Group to distribute its products in Australia. This partnership aims to expand INBS's market reach and enhance its distribution capabilities in the region.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:35 pm

ATNF

180 Life Sciences Corp. has regained compliance with Nasdaq's minimum stockholders' equity rule, allowing it to focus on its new iGaming business and biotechnology programs.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:35 pm

SVRE

SaverOne has signed a new distribution agreement with Sistemas ADAS to expand its reach in Spain and Portugal. This move is part of its European growth strategy, following recent market entries into Italy and Mexico, and a US distribution agreement.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:33 pm